Celastrol Inhibits Inflammatory Stimuli-Induced Neutrophil Extracellular Trap Formation
Journal:
Current Molecular Medicine
Volume:
15
Page:
401-410
Author(s):
Y. Yu, C.D. Koehn, Y. Yue, S. Li, G.M. Thiele, M.P. Hearth-Holmes, T.R. Mikuls, J.R. O’Dell, L.W. Klassen, Z. Zhang and K. Su
TNF as a Target of Inflammation in Rheumatoid Arthritis
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
15
Page:
129-134
Author(s):
Hisashi Yamanaka
Comparison of In Vitro and In Vivo Effects of Infliximab on Cytokine Production in Proliferating CD4+ T Cells in Patients with Rheumatoid Arthritis
Journal:
Clinical Anti-Inflammatory & Anti-Allergy Drugs (Discontinued)
Volume:
1
Page:
122-128
Author(s):
Syuichi Koarada, Yuri Sadanaga, Natsumi Nagao, Satoko Tashiro, Rie Suematsu, Akihide Ohta and Yoshifumi Tada
Acute Kidney Injury, Hyperbilirubinemia, and Ischemic Skin Necrosis Due to Massive Sulindac Overdose
Journal:
Current Drug Safety
Volume:
10
Page:
190-192
Author(s):
John L. Vaughn, Kejal V. Shah, Maroun M. Ghossein, William L. Meyer and Robert B. Kirkpatrick
Cardiovascular Effects of Methotrexate in Rheumatoid Arthritis Revisited
Journal:
Current Medicinal Chemistry
Volume:
22
Page:
1903-1910
Author(s):
Tatyana V. Popkova, Diana S. Novikova, Armen Yuri Gasparyan and Evgeny L. Nasonov
Biological Therapies: Effects of Proinflammatory Pathways and their Inhibition on the Myocardium of Rheumatoid Athritis Patients
Journal:
Current Medicinal Chemistry
Volume:
22
Page:
1911-1929
Author(s):
Florian Obermair and Herwig Pieringer
Tumor Necrosis Factor Blocking Therapy and Congestive Heart Failure in Patients with Inflammatory Rheumatic Disorders: A Systematic Review
Journal:
Current Medicinal Chemistry
Volume:
22
Page:
1892-1902
Author(s):
S.C. Heslinga, A.M. Van Sijl, K. De Boer, V.P. Van Halm and M.T. Nurmohamed
Interleukin-6 In Rheumatoid Arthritis - From The Laboratory To The Bedside
Journal:
Current Pharmaceutical Design
Volume:
21
Page:
2187-2197
Author(s):
Xiao Liu, Andrew J. Teichtahl and Ian P. Wicks
Rheumatoid Arthritis: An Evolutionary Force in Biologics
Journal:
Current Pharmaceutical Design
Volume:
21
Page:
2170-2178
Author(s):
Philip M. Brown and John D. Isaacs
Rheumatology: A Force for Change in Monoclonal Antibodies
Journal:
Current Pharmaceutical Design
Volume:
21
Page:
2179-2186
Author(s):
David C. Lowe and Tristan J. Vaughan